In disease, IdoA contributes to cancer progression and infection. New avenues for future therapies have been tested, such as vaccination against cancer 67–69, or are warranted to control infection 65,66 and cancer 13,76,77. DS epimerases inhibitors could be used in cancer and fibrosis, as well as to guide stem cell differentiation 3.
